Discussion

Monday, March 10, 2025

9:12 AM - 9:24 AM ET

Panel Moderator(s)

Megan Coylewright, MD, MPH

Editor
American College of Cardiology CardioSmart, Tennessee, United States

No relationships to disclose
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

No relationships to disclose

Panel Discussant(s)

Wayne Batchelor, MD, MHS

Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States

No relationships to disclose
Samuel Conaway, MBA

President Cardiology Sales
Boston Scientific Corporation

No relationships to disclose
Kendra J. Grubb, MD

VP/CMO Structural Heart
Medtronic
Atlanta, Georgia, United States

Disclosure information not submitted.
Tenley Koepnick

Vice President, Global Clinical Affairs
Edwards Lifesciences

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Megan Coylewright, MD, MPH: Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC: No financial relationships to disclose

Wayne Batchelor, MD, MHS: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi USA: Consulting Fees (e.g., advisory boards) (Ongoing)

Samuel Conaway, MBA: No financial relationships to disclose

Kendra J. Grubb, MD: Medtronic: Employee (Ongoing)

Tenley Koepnick: No financial relationships to disclose